Cyclohexylphenols
Search Within Results
46
–
60
of
344
results
46
Aobchem 4-Bromo-2-fluoro-6-methylphenol | ≥97% | CAS 945557-29-9 | C7H6BrFO | 500mg
4-Bromo-2-fluoro-6-methylphenol | ≥97% | CAS 945557-29-9 | C7H6BrFO | 500mg
47
Aobchem 2-Bromo-3-fluoro-4-methylphenol | ≥97% | CAS 1643457-64-0 | C7H6BrFO | 250mg
2-Bromo-3-fluoro-4-methylphenol | ≥97% | CAS 1643457-64-0 | C7H6BrFO | 250mg
48
Aobchem 6-Bromo-3-fluoro-2-methylphenol | ≥97% | CAS 1559064-08-2 | C7H6BrFO | 1g
6-Bromo-3-fluoro-2-methylphenol | ≥97% | CAS 1559064-08-2 | C7H6BrFO | 1g
49
![Medchemexpress LLC 3-[[[5-(6-Methyl-2-pyridinyl)-4-triazolo[1,5-a]pyridin-6-yl-1H-imidazol-2-yl]methyl]amino]benzonitrile | 1352609-28-9 | 98.8% | 406.44 | C23H18N8 | 10 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000299221.png-250.jpg)
Medchemexpress LLC 3-[[[5-(6-Methyl-2-pyridinyl)-4-triazolo[1,5-a]pyridin-6-yl-1H-imidazol-2-yl]methyl]amino]benzonitrile | 1352609-28-9 | 98.8% | 406.44 | C23H18N8 | 10 MG
EW-7195 is a potent, selective ALK5 (TGFβR1) inhibitor for research use that blocks TGF-β1-induced Smad signaling, epithelial-to-mesenchymal transition, and metastatic progression in preclinical studies. It provides low-nanomolar potency and is supplied with high purity for laboratory assays.
- Potent ALK5 inhibition with low-nanomolar IC50.
- High selectivity over related kinases, >300-fold versus p38α.
- Blocks TGF-β1-induced Smad signaling and epithelial-to-mesenchymal transition.
- Demonstrated anti-metastasis activity in preclinical models.
- High purity suitable for research applications.
- Soluble in DMSO for assay preparation.
50
51
52
53
54
55
56
57
58
59
60